Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8620
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoharman, Joharman-
dc.contributor.authorPoerwono, Hadi-
dc.contributor.authorSukardiman, Sukardiman-
dc.date.accessioned2024-11-30T02:27:46Z-
dc.date.available2024-11-30T02:27:46Z-
dc.date.issued2021-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8620-
dc.description.abstractBackground: The species from the genus Garcinia has long been used as traditional medicine for cancer treatment. Objective: To analyze the phytochemical contents and assess the cytotoxic effects of pericarp extracts of Garcinia forbesii King against MCF-7 breast cancer cells and HepG2 liver cancer cells. Materials and Methods: The phytochemical contents were analyzed using the thin-layer chromatography and the cytotoxic activity was assessed using the MTT assay method. Results: Phytochemical screening showed the presence of alkaloids, flavonoids, terpenoids and polyphenols. The cytotoxic activities of n-hexane, DCM and ethyl acetate extracts on MCF-7 cells were shown with IC50 103.605±2.3410 μg/ mL, 397.609±28.0534 μg/mL and 1,518.301±68.6379 μg/mL respectively, while the IC50 on HepG2 cells were 79.798±1.2261 μg/mL, 83.230±4.2557 μg/mL and 671.875±94.3338 μg/mL respectively. Conclusion: The n-hexane, DCM and ethyl acetate extracts from pericarps of G. forbesii King have cytotoxic activities against MCF-7 and HepG2 cancer cells, therefore, it has the potential to be developed as an anticancer. Key words: Garcinia forbesii King., Cytotoxic, MCF-7, HepG2, Anticancer.en_US
dc.subjectGarcinia forbesii King., Cytotoxic, MCF-7, HepG2, Anticanceren_US
dc.titleCytotoxicity Effect of the Pericarp Extracts of Garcinia forbesii King on MCF-7 Breast Cancer and HepG2 Liver Cancer Cell Linesen_US
dc.typeArticleen_US
Appears in Collections:VOL 13 NO 1 2021

Files in This Item:
File Description SizeFormat 
33.pdf604.09 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.